Literature DB >> 12151033

Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease.

Suhail Kasim1, H A Jinnah.   

Abstract

Congenital deficiency of hypoxanthine-guanine phosphoribosyl transferase (HPRT) causes Lesch-Nyhan disease in humans, which is associated with severe and recurrent self-injurious behavior (SIB). The HPRT-deficient knockout mouse model, however, does not display this unusual behavior. The present studies tested whether these mice might be more vulnerable to pharmacologic agents known to cause SIB in normal rodents, including clonidine, Bay K 8644, GBR 12909, methamphetamine, pemoline and caffeine. The results provided three conclusions. First, normal mice did not display SIB using some drugs known to provoke the behavior in rats (GBR 12909, caffeine), indicating important species differences in the expression of the behavior. Second, the C57BL/6J mice did not display SIB using drugs effective for other strains of mice (methamphetamine, pemoline), indicating important strain differences in expression of the behavior. Finally, there was no evidence that the HPRT-deficient mice were more susceptible to SIB when it occurred (clonidine, Bay K 8644).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151033     DOI: 10.1016/s0091-3057(02)00841-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Nifedipine suppresses self-injurious behaviors in animals.

Authors:  Bonita L Blake; Amber M Muehlmann; Kiyoshi Egami; George R Breese; Darragh P Devine; H A Jinnah
Journal:  Dev Neurosci       Date:  2006-10-17       Impact factor: 2.984

2.  Dopamine Release and Uptake Impairments and Behavioral Alterations Observed in Mice that Model Fragile X Mental Retardation Syndrome.

Authors:  Jenny L Fulks; Bliss E O'Bryhim; Sara K Wenzel; Stephen C Fowler; Elena Vorontsova; Jonathan W Pinkston; Andrea N Ortiz; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2010-10-20       Impact factor: 4.418

Review 3.  The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.

Authors:  Alan Regenberg; Debra J H Mathews; David M Blass; Hilary Bok; Joseph T Coyle; Patrick Duggan; Ruth Faden; Julia Finkel; John D Gearhart; Argye Hillis; Ahmet Hoke; Richard Johnson; Michael Johnston; Jeffrey Kahn; Douglas Kerr; Patricia King; Joanne Kurtzberg; S Matthew Liao; John W McDonald; Guy McKhann; Karin B Nelson; Mahendra Rao; Andrew W Siegel; Kirby Smith; Davor Solter; Hongjun Song; Jeremy Sugarman; Angelo Vescovi; Wise Young; Henry T Greely; Richard J Traystman
Journal:  J Cereb Blood Flow Metab       Date:  2008-08-27       Impact factor: 6.200

4.  Generation of Hprt-disrupted rat through mouse←rat ES chimeras.

Authors:  Ayako Isotani; Kazuo Yamagata; Masaru Okabe; Masahito Ikawa
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.